R&D expertise

We develop intelligent healthcare solutions – always with a focus on translation into applications for the market.

Interdisciplinarity is our strength

With a view to the needs of tomorrow, our research and development expertise represents the focus of our work and provides a framework for intelligent healthcare solutions – always with a focus on translation into applications for the market.

Many of our ideas and innovations emerge at the interface between medical science, natural science, computer science and engineering – this interdisciplinarity is our strength. For more than four decades, we have been transferring findings and know-how into values, services and products for society and humankind, pursuing our vision of being “pioneers for sustainable health”.  

 

Fraunhofer vs. Corona

As an institute with decades of experience in infection and airway research, drug development, biomedical engineering and in the field of chemical risk assessment, Fraunhofer ITEM can make an important contribution to scientific progress in the fight against the coronavirus SARS-CoV-2.

For more than four decades, we have been developing solutions for human health

 

Cardiopulmonary research

Through the establishment of a Division of Cardiovascular Research in 2021, the long-standing expertise in lung research is experiencing a synergetic further development of high clinical relevance. 

Medical and Pharmaceutical Engineering

Next to innovative inhalation technologies, our focus is on developing novel technologies for administration of therapeutic aerosols by means of smart drug/device combination products.

 

Malignant disease research

The Fraunhofer ITEM Division of Personalized Tumor Therapy in Regensburg is aimed at understanding a patient’s individual condition, establishing appropriate diagnostics and optimizing therapies.

Bioinformatics and AI

Our researchers develop methods for preparation, analysis and visualization of biomedical data, as well as data models and data analysis pipelines. The focus is on the mapping of cellular and regulatory processes and their translation into applications.

 

Toxicology

Based on the next generation risk assessment concept, Fraunhofer ITEM develops new assessment strategies to provide predictive models for assessing the safety of compounds, active pharmaceutical ingredients and drugs.

 

Immunology and infection research

The development, formulation and mode of delivery of anti-infective agents, for example for inhaled administration as drug aerosols, are research topics of current interest at the institute.

Privacy warning

With the click on the play button an external video from www.youtube.com is loaded and started. Your data is possible transferred and stored to third party. Do not start the video if you disagree. Find more about the youtube privacy statement under the following link: https://policies.google.com/privacy

Research at Fraunhofer ITEM is focused on human health – and this has been so for over four decades.